Helicobacter hepaticus infection induces sustained inflammation and carcinoma of the liver in A/JCr mice, and serves as a model of human cancers associated with viral hepatitis and H. pylori chronic gastritis. Here we describe the pathogenesis of premalignant disease in A/JCr mice infected with H. hepaticus. We inoculated dams intragestationally and/or pups postnatally, and evaluated offspring at 3, 6, or 12 months. Mice infected at or before 3 weeks of age, but not at 12 weeks, developed disease. Male mice were most affected, but expressed a bimodal pattern of susceptibility. Males exhibited lobular necrogranulomatous and interface (chronic active) hepatitis, while females usually developed intraportal (chronic persistent) hepatitis. Portal inflammation was slowly progressive, with tertiary lymphoid nodule development by 12 months. Hepatic bacterial load and preneoplastic lesions, including clear and tigroid cell foci of cellular alteration, were correlated with lobular hepatitis severity. No extrahepatic surrogate disease marker reliably predicted individual hepatitis grade. In conclusion, gender and bacterial exposure timing are key determinants of H. hepaticus disease outcomes. Intrahepatic inflammation is driven by local signals characterized by a vigorous but nonsterilizing immune response. Continued study of chronic hepatitis progression may reveal therapeutic targets to reduce the risk of hepatocellular carcinoma.
INTRODUCTION
Hepatocellular carcinoma (HCC), which usually arises in a setting of chronic hepatitis, is the third leading cause of human cancer deaths worldwide (Shibuya et al., 2002) . Most patients diagnosed with HCC are seropositive for hepatitis B virus, hepatitis C virus, or both (Waris, 2003) . Men develop HCC at more than 3 times the rate of women regardless of inciting cause, suggesting that perturbations of sexually dimorphic metabolic pathways predispose to tumorigenesis (Kew, 2002) . Complex interactions between host and pathogen in human infectious liver cancer, especially in early disease, are difficult to evaluate. Animal models can be used to help unravel pathogenetic mechanisms in the progression from hepatitis to malignancy . Whereas liver cancer in humans and murine models has been extensively investigated, fewer studies have characterized in detail the chronic inflammation which predisposes to carcinogenesis.
Helicobacter hepaticus infection of A/JCr and other susceptible mice induces chronic hepatitis and hepatocellular tumors (Fox et al., 1994; Ward et al., 1994b) . H. hepati-cus is the prototype enterohepatic Helicobacter species, and closely related organisms are now known to commonly infect humans and a wide array of animals (Fox et al., 1996a (Fox et al., , 1996b Fox, 1998; Solnick and Schauer, 2001; Garcia et al., 2002) . H. pylori infection is the leading cause of human gastric cancer , and hepatobiliary Helicobacter spp. have been implicated as liver tumor promoters in people, either alone or superimposed on viral hepatitis (Fox et al., 1998a; Nilsson et al., 2000; Ponzetto et al., 2000; Dore et al., 2002; Fan et al., 2002; Fukuda et al., 2002; Leong and Sung, 2002; Matsukura et al., 2002) . In mice, enterohepatic Helicobacter spp. promote chemically initiated liver tumors (Diwan et al., 1997) , and are the only infectious pathogens known to act as complete hepatocarcinogens. Thus, H. hepaticus infection provides a uniquely valuable rodent model for exploring basic mechanisms underlying inflammation-associated liver cancer. Although the carcinogenic potential of H. hepaticus infection in susceptible mouse strains has been proven (Fox et al., 1996a; Hailey et al., 1998; Ward et al., 1994b) , disease progression in the premalignant period has received less attention. In this report we characterize the pathogenesis of chronic hepatitis and preneoplasia over a 12-month period in A/JCr mice exposed to H. hepaticus at different stages of antenatal, neonatal, and/or postnatal development. Clinicopathologic findings correlated well with global transcriptome changes in the liver (Boutin et al., 2004 ). An ancillary aim was to evaluate the influence of the timing of H. hepaticus exposure on subsequent disease expression and progression. Increased understanding of preneoplastic events in this murine model of inflammationassociated HCC will enhance our knowledge of basic mechanisms in human hepatitis and liver cancer, and may elucidate novel targets for therapeutic intervention prior to the onset of malignancy. 
METHODS

Study Design
Thirty-six helicobacter-free female A/JCr mice (National Cancer Institute, Frederick, MD) were bred to 18 males, and pregnant dams were divided into groups. Dams received 10 7 colony-forming units H. hepaticus or vehicle only by gastric gavage every 48 hours for 3 doses at conception (confirmed by vaginal plug visualization) or beginning midway (day 10) through pregnancy. Pups received a similar bacterial or sham inoculum regimen at 3 or 12 weeks postnatally (Table 1) . Assessment of transplacental bacterial or antigenic exposure was not performed. Offspring were euthanatized by CO 2 inhalation at 3, 6, or 12 months of age. A total of 117 mice were evaluated: 33 at 3 months, 41 at 6 months, and 43 at 12 months. Animals were maintained in a facility certified by the Association for the Assessment and Accreditation of Laboratory Animal Care in compliance with the National Academy of Sciences' Guide for the Care and Use of Laboratory Animals, and all protocols were approved by the Massachusetts Institute of Technology (MIT) Committee on Animal Care.
Hemogram and Serum Chemistry
Hemograms were performed in-house according to standard protocols. Serum from mice collected at 3 and 6 months of age was separated from packed cells by centrifugation and sent to a reference laboratory (Idexx Laboratories, North Grafton, MA) for serum biochemical analysis including alkaline phosphatase (ALP), direct and indirect bilirubins, cholesterol, γ -glutamyl transferase, aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, and globulin. Hemogram and serum chemistry value differences between groups were assessed by 1 way analysis of variance (ANOVA), followed by Dunnett's pairwise posttest using Prism 3.0cx software for Macintosh (GraphPad, San Diego, CA).
Antibody and Restimulated Splenocyte Cytokine Titers
H. hepaticus-specific serum IgG 1 and IgG 2a titers were determined by ELISA using a previously described method (Whary et al., 2000) . Spleens were aseptically collected, dissociated, maintained in primary culture, and exposed to sterile-filtered whole bacterial H. hepaticus sonicate or medium only. Supernatants were collected at 48 hours' poststimulation and assayed for tumor necrosis factor-α (TNF-α) and interferon-γ by ELISA as previously described (Whary et al., 1998) . Statistical analyses were performed by ANOVA or unpaired t test using the statistical package of Microsoft Excel (Seattle, WA). Fecal pellets were emulsified in protease inhibitor (Sigma, St. Louis, MO), debris separated by centrifugation, and supernatant analyzed for anti-H. hepaticus IgA titers by ELISA as described (Whary et al., 1998) .
DNA PCR
DNA was extracted from feces and frozen liver sections using a commercial kit (DNeasy Tissue Kit, Qiagen, Carlsbad, CA). Nested DNA PCR was performed using genus-specific primers in the first round that amplify a ∼1200 base-pair (bp) sequence in the 16S rRNA gene using a previously described protocol (Fox et al., 1996b) . Ten percent of first-round product was amplified in a second round using H. hepaticusspecific primers to amplify a 417 bp product nested within the first round amplicon (Fox et al., 1998b) . Samples positive for bacterial DNA by nested PCR, as well as uninfected negative controls, were quantitated by real-time fluorogenic PCR (TaqMan) according to a previously described protocol .
Histopathology
At necropsy, ileocecocolic junction and 2 sagittal sections of each liver lobe (median, caudate, left, and right) were collected for histopathology. Tissues were immersion fixed overnight in 10% neutral-buffered fromalin (VWR Scientific, West Chester, PA) and Prefer (Anatech, Ltd., Battle Creek, MI). Fixed tissues were processed and embedded by routine histologic methods, sectioned at 4 µm, and stained with hematoxylin and eosin (H&E). The 8 liver sections representing replicate samples from each lobe were examined by a veterinary pathologist blinded to sample identity and TOXICOLOGIC PATHOLOGY graded on a 0-4 scale for lobular histologic activity (lobular hepatitis), portal activity (portal and/or interface hepatitis), and staged on the same scale for fibrosis using criteria established by Scheuer (Ferrell et al., 2002; Scheuer et al., 2002) .
Additionally, dysplastic progression was scored using criteria adapted from published schemes for the terminology of rodent and human liver lesions: (0) normal, (1) foci of cellular alteration or dysplastic foci, (2) nodules of cellular alteration or low grade dysplastic nodules, (3) high-grade dysplastic nodules or focal well differentiated HCC, and (4) multifocal and/or moderately differentiated HCC (IWP, 1995; Bannasch et al., 2001) . Statistical comparison of mean histologic activity scores by ANOVA was not possible because the bimodal distribution in infected males produced large standard deviations (see Results). Therefore, we categorized by the presence or absence of moderate-to-severe hepatitis (defined as lobular or portal histologic activity ≥2 in any lobe; Table 1 ) and performed contingency table analyses. Contingency tables were assessed by Fisher's exact test using Prism software as described before.
Special Stains, Immunohistochemistry, and Morphometric Analysis
Selected liver sections were stained by the Warthin-Starry stain for visualization of bacteria, or diastase periodic acid-Schiff or Perl's iron for demonstration of activated macrophages. Formalin-and Prefer-fixed liver sections were subjected to standard microwave heat-induced epitope retrieval and immunostained for cell phenotype markers or specific biomolecules using mouse monoclonal or rabbit polyclonal primary antibodies according to previous methods (Erdman et al., 2003a; Fox et al., 2003b) . For mouse primary antibodies the ARK kit was used (DAKO, Carpinteria, CA), a system that employs prelabeled same-species antibodies to overcome labeling of endogenous immunoglobulins, a strategy proven in other settings . Rabbit primary antibodies were labeled with biotinylated goat anti-rabbit IgG (Sigma). Cell phenotypes and other biomolecules included T cells (rabbit anti-CD3, Sigma), B cells (CD45R/B220) and the mitosis marker Ki-67 (BD Pharmingen, San Diego, CA), macrophages (F4/80, Caltag Laboratories, Burlingame, CA), iNOS (NOS2) and COX-2 (PGH2; Santa Cruz Biotechnology, Santa Cruz, CA), and the apoptosis marker cleaved caspase-3 (Cell Signaling Technology, Beverly, MA). Diaminobenzidine (DAB) or Vector VIP was used as chromogen, and tissues were counterstained with Gill's hematoxylin. Morphometric analysis of immunohistochemically stained tissue sections was performed using IPLab 3.6 software for Macintosh (Scanalytics, Inc., Fairfax, VA) according to previously described methods .
RESULTS
Hemogram and Serum Chemistry
Offspring infected with H. hepaticus had higher mean white blood cell (WBC) counts than uninfected controls at 3 months of age. Statistical analysis by ANOVA revealed significant ( p < 0.05) differences between infected and uninfected groups at 3 months for WBC and absolute lymphocyte FIGURE 1.-Circulating white blood cell counts (WBC) in uninfected (group 1) versus H. hepaticus-infected mice (groups 2-9, Table 1 ) at 3 and 6 months (leukocytes other than neutrophils and lymphocytes comprised <2% of WBC). * p < 0.05 versus controls.
counts, but not for other leukocytes (Figure 1 ). There were no significant differences in mean WBC counts between infected and uninfected groups at 6 months (Figure 1) or 12 months, demonstrating that circulating leukocytosis returned to background levels between 2 and 5 months postinoculation. At no collection point were there significant differences in erythrocyte parameters or platelet counts. Increased serum levels of ALT and AST were evident in some groups of infected mice, but not others ( Figure 2 ).
Mean combined ALT and AST levels in infected versus uninfected mice were 55 vs. 29 IU/L ( p = 0.11) and 198 vs. 80 IU/L ( p = 0.06), respectively. There was no difference in ALP levels between infected and uninfected mice (91 vs. 100 IU/L, respectively; p = 0.40) or any other analyte in the liver panel. In summary, serum chemistry demonstrated that cellular damage associated with H. hepaticus infection was inconsistent and limited to hepatocytes. Whereas mean serum aminotransferase levels tended to be increased in groups of infected mice, there was no correlation with liver lesion severity in individual animals as determined by histopathology.
Antibody and Restimulated Splenocyte Cytokine Titers
All mice infected with H. hepaticus developed and maintained moderate to high antigen-specific mucosal IgA responses detected in fecal extracts, as well as serum IgG 1 and IgG 2a responses (Figure 3 ). Whereas there was no correlation between IgA titers and inoculation protocol or hepatitis grade, mucosal IgA levels were higher in infected females than males, especially at 12 months ( p = 0.007; Figure 3 ). There were no significant differences in serum antibody responses between infected groups in chronic disease. Serum antibody levels peaked at 6 months ( p < 0.001) but did not correlate with gender or severity of hepatitis. From the 3month to 6-month time point, IgG 2a levels increased proportionately more than IgG 1 , and between 6 and 12 months, IgG 1 levels decreased to a greater extent than IgG 2a (Figure 3 ). Restimulated splenocyte interferon-γ and TNF-α responses (not shown) were not significantly different between infected and uninfected mice, nor was there any correlation with gender, inoculation protocol, or hepatitis severity. Vol. 32, No. 6, 2004 H. Hepaticus HEPATITIS AND PRENEOPLASIA 671 FIGURE 2.-Composite 3-and 6-month mean serum chemistry enzyme values (±SD) for alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in groups of uninfected and H. hepaticus-infected mice as shown in Table 1 . 
PCR
All infected mice were positive, and all control mice were negative, for H. hepaticus in feces following a single round of standard DNA PCR. A direct correlation emerged in liver samples between nonquantitative nested bacterial DNA PCR, quantitative fluorogenic DNA PCR (TaqMan), and lobular histologic activity (described next), especially among male mice at the 12-month collection point (Figure 4) . At 12months the mean number of copies of bacterial DNA per µg host DNA in mice with a positive first round standard PCR signal was 1.3 × 10 6 in males and 3.4 × 10 3 in females (Figure 4) . In nearly all instances, samples requiring 2 rounds of nested PCR to demonstrate signal were below the sensitivity threshold of the single-round fluorogenic assay. The median histologic activity grade of male mice with a positive first round standard DNA PCR signal was 3, versus 1 in males without first-round signal ( p < 0.001; Figure 4) . The difference was less striking in females (2 versus 1), but still approached statistical significance ( p = 0.09; Figure 4 ). Thus, detection of intrahepatic bacterial DNA after one round of standard DNA PCR was associated with high bacterial load and severe hepatitis, especially in male mice at 12 months. Retrospective PCR-based analysis of archived mouse liver sections has proven useful for identifying H. TOXICOLOGIC PATHOLOGY hepaticus as a confounding factor in mouse carcinogenesis studies (Malarkey et al., 1997) .
Histopathology
Inflammatory lesions in mice infected with H. hepaticus followed one of two courses, resulting in necrogranulomatous lobular and/or lymphocytic portal hepatitis. These histologic presentations correlated with descriptions of human "chronic active" and "chronic persistent" hepatitis, though such terminology is falling from favor (Brunt, 2000) . In cases of lobular hepatitis, necroinflammatory lesions consisted primarily of Küpffer cells and recruited macrophages surrounding and infiltrating foci of spotty or confluent hepatocellular necrosis (Figure 5a ), resulting in translobular coagulative necrosis in severe cases. Neutrophils and lymphocytes made a minority contribution to lobular lesions. Larger lesions were evident grossly as round white foci up to 2 mm diameter. Lobular lesions were often but not always situated near terminal hepatic venules. Acidophil bodies were mildly increased in number in mice with lobular hepatitis, though not always located near inflammatory foci. Fibrosis was not a prominent feature of disease.
Portal hepatitis consisted primarily of lymphocytoid cells forming expansile nodular lesions, either in conjunction with lobular lesions or comprising the main disease process. Uncomplicated portal hepatitis was most common in females. Because bacteria were rarely identified in portal regions, it is possible these lesions developed due to circulating antigens or cytokines from the lower bowel. Lobular necrogranulomatous lesions were evident at all sampled timepoints, whereas chronic portal inflammation was not fully developed until 12 months of age. Especially in conjunction with lobular lesions, portal mononuclear infiltrates disrupted the hepatic limiting plate, resulting in interface hepatitis (Figure 5b ). Lymphocytoid cells filled and expanded reactive portal lymphatic vessels, and in larger lesions surrounded and infiltrated bile ductules inducing epithelial loss, hypertrophy, and atypia (Figure 5b ). Expansile aggregates sometimes were organized into follicles consistent with "tertiary lymphoid tissue" (Figure 5c ) (Shomer et al., 2003) . Unlike the case of H. hepaticus infection in mice with targeted immune mutations (Erdman et al., 2003a (Erdman et al., , 2003b Tomczak et al., 2003; Young et al., 2004) , but in agreement with previous studies utilizing A/JCr mice (Whary et al., 1998 , inflammation of the cecum and colon (typhlocolitis) in these immunocompetent animals was generally mild, with inflammation scores typically in the range of 0.5-1 out of 4. Typhlocolitis was limited to mice infected at or before 3 weeks of age, but was not present in all animals, and there were no statistically significant differences between groups. Although morphologic changes were mild, microarray experiments have shown that lower bowel colonization of A/JCr mice with H. hepaticus induces prominent transcriptional responses (Myles et al., 2003) .
At 12 months of age, male mice with severe lobular hepatitis exhibited dysplastic and proliferative lesions similar to those previously documented (Ward et al., 1994a (Ward et al., , 1994b Rice, 1995; Canella et al., 1996; Fox et al., 1996a Fox et al., , 1998 Hailey et al., 1998; Haseman et al., 1998; Bannasch et al., 2001) . Foci of cellular alteration or dysplastic foci were multifocal, and often merged imperceptibly into adjacent zones of more normal hepatocytes. In some instances expansile dysplastic nodules were sharply delineated from surrounding less affected lobules (Figure 5d ). Inflammation was concentrated at the perimeter of dysplastic nodules. Foci of cellular alteration, putative precursors to HCC (Bannasch et al., 1985 (Bannasch et al., , 2001 , were of the clear cell, eosinophilic, or basophilic-tigroid ( Figure 5e ) phenotype, often comingled. Hepatocellular atypia was manifest as marked anisocytosis and anisokaryosis, structural and tinctorial pleomorphism, irregular cytoplasmic vacuolation and molding, aberrent multinucleation, and nuclear clearing with bizarre chromatin patterns. Oval cell hyperplasia, with occasional pseudocholangiole formation (Figure 5f ), was common within foci of cellular alteration.
Special Stains and Immunohistochemistry
Confirmation of the primarily granulomatous nature of lobular necroinflammatory lesions was provided by F4/80 immunohistochemistry (Figure 5g ). As described in human viral hepatitis, activated macrophages containing diastaseresistant PAS-positive material were present in some inflammatory lesions (Ferrell et al., 2002) . In contrast, phagocytes with accumulated iron were extremely rare. Argyrophilic spiral bacteria, some undergoing longitudinal fission, were readily identified in bile canaliculi of Warthin-Starry-stained liver sections near histologically active lobular lesions, but were rare near portal tracts. In agreement with PCR results, organisms were absent in uninfected mice, and very rarely visualized in Warthin-Starry-stained liver sections from mice lacking lobular inflammation. Immunohistochemical demonstration of iNOS and COX-2 was limited to necroinflammatory lesions; however, the cell populations expressing each of these proteins were different. iNOS was demonstrated almost exclusively within inflammatory cells (Figure 5h ), while COX-2 was up-regulated in intralesional hepatocytes (Figure 5i ). Scattered acidophil bodies and some leukocytes, but not sheets of hepatocytes within zones of coagulative necrosis, contained cleaved caspase-3.
Morphometric Analysis
Observational quantitation of lesions in liver sections proved problematic due to variable densities of leukocellular aggregation, and confluence of adjoining inflammatory foci. We therefore applied morphometric analysis to 5 affected and 2 control immunohistochemically stained livers from the 12month time point in order to determine percent area occupied by specific cell subsets within a defined region of interest . We examined 10 left lobe fields per mouse under the 10X objective (0.61 mm 2 /field). In mice with lobular and/or portal hepatitis (histologic activity ≥2), the median hepatic tissue area comprised of leukocyte-common antigen CD45 + white blood cells was 4%. One liver with severe disease contained 9% leukocytes, and when leukocytes were combined with zones of coagulative necrosis 25% of the most affected lobe was effaced. Portal tertiary lymphoid nodules contained a median of 72% CD45 + leukocytes, the remaining tissue being comprised of resident portal arterioles, bile ductules, lymphatic channels, and connective tissue (portal venules were excluded from the manually defined region of interest).
Among the inflammatory cells, 45% displayed the B cell marker CD45R/B220 (Figure 5j ), 7% were CD3 + T cells Vol. 32, No. 6, 2004 H. Hepaticus HEPATITIS AND PRENEOPLASIA 673 TOXICOLOGIC PATHOLOGY (Figure 5k) , and 3% were identified as F4/80 + professional antigen-presenting cells (macrophages ± dendritic cells). Unlabeled portal tertiary lymphoid tissue included arterioles and bile ducts as well as presumptive NK cells, scattered granulocytes, and other cells unrecognized by our antibody panel. Within tertiary lymphoid nodules, B cells were aggregated into follicular structures (Figure 5j ) while T cells (Figure 5k ) and antigen-presenting cells were more widely dispersed. In portal tracts where bile ducts were surrounded and transmigrated by leukocytes, ductular epithelium exhibited atrophy, hypertrophy, and decreased cytokeratin expression. Scattered throughout portal tertiary lymphoid tissue, and focally concentrated at the periphery, were many actively proliferating cells attesting to intrahepatic lymphoid expansion (Figure 5l ). The Ki-67 labeling index per X10 field was 104 in tertiary lymphoid tissue. Increased cell proliferation was also evident in foci of cellular alteration and dysplastic nodules, with a Ki-67 labeling index of 7 hepatocyte nuclei per X10 field, versus <1 in normal hepatic lobules ( p < 0.0001).
Statistical Analysis of Disease Distribution
We categorized mice with lobular histologic activity ≥2 as having lobular hepatitis even though most also demonstrated significant portal inflammation. The assignment of portal hepatitis was reserved for those with histologic activity ≥2 exclusively in portal regions (Table 1 ). In agreement with previous studies (Ward et al., 1994b; Fox et al., 1996a; Whary et al., 1998) , these experiments demonstrated a significantly higher risk of lobular hepatitis in male mice. Among groups infected with H. hepaticus at 3 weeks of age or earlier, 44% of males (24/54) but only 3% of females (1/37) developed lobular hepatitis ( p < 0.0001; Figure 6a ). In contrast, males and females were at equal risk for portal hepatitis at the 12-month time point (6/19 and 6/14, respectively; p = 0.75; Figure 6a ).
When combined, a distinct bimodal distribution pattern of histologic activity scores emerged among males, with clustering of groups at the upper and lower ends of the spectrum attributable to lobular activity, while female hepatitis scores presented a Guassian distribution with most of the higher scores representing portal activity (Figure 6b) . The "all-ornone" phenomenon in males resulted in large standard deviations, necessitating contingency table analyses (see Methods) . Pattern analyses of male mice with and without lobular hepatitis revealed no correlations based on sibling status or cage distribution. No mice in the group infected at 12 weeks of age developed significant hepatitis ( p = 0.02). Thus, early exposure to H. hepaticus was essential to induce disease.
Inflammatory lesion severity was highly variable between liver lobes in mice with disease, and even in focally severe cases some lobes were usually spared. Therefore, microscopic evaluation of all liver lobes was essential to rule out hepatitis. Among the 46 mice with moderate-to-severe hepatitis at any time point, a median of 2 (±1) out of 4 liver lobes demonstrated a histologic activity grade ≥2. Inflammatory foci were randomly distributed between and within lobes, presumably reflecting bacterial migration patterns. Likewise, there was no consistent intralobular lesion distribution, although pericentral foci were common. All male mice at the 12-month time point with lobular hepatitis scores ≥2 also exhibited putatively preneoplastic foci or nodules of altered hepatocytes, and no mice in any other group had such lesions ( p < 0.0001). Thus, there was a strong association between necrogranulomatous lobular hepatitis and early tumorigenic progression in male mice infected with H. hepaticus, as described in older literature linking human "chronic aggressive hepatitis" with risk of hepatocellular carcinoma (Brunt, 2000) .
DISCUSSION
In this report we characterize in detail the progression of chronic hepatitis and dysplasia in the premalignant phase of a mouse model of infectious liver cancer. We show that early exposure to H. hepaticus is required for disease susceptibility. Male mice are more prone to severe disease than females, but only a subset of males are affected. Disease severity correlates directly with intrahepatic bacterial load. Taken together, our results demonstrate that chronic hepatitis is driven by a vigorous but nonsterilizing immune response to H. hepaticus. Vol. 32, No. 6, 2004 H. Hepaticus HEPATITIS AND PRENEOPLASIA 675 These findings were confirmed by microarray analysis documenting progressive transcriptome changes over time (Boutin et al., 2004) . It has been proposed that autoimmunity, especially to heat shock protein 70, may contribute to hepatocellular damage in H. hepaticus infection (Ward et al., 1996) . Systemic and extrahepatic surrogate disease markers including complete blood count, serum chemistry values, circulating and mucosal antibody titers, and restimulated splenocyte cytokine responses, fail to predict hepatitis severity in individual animals, suggesting that intrahepatic inflammation is governed by local signals. H. hepaticus persists as a lifelong infection in the cecum and colon of mice. An important question requiring further study is whether bacterial containment in mice that do not develop hepatic disease occurs at the level of the large bowel, the liver, or both. Higher fecal IgA titers could help explain relative resistance to liver disease in female versus male mice, but the absence of correlation between fecal IgA titer and hepatitis severity implies that other factors must also be involved. Likewise in humans, serology is useful for the diagnosis of H. pylori infection, but is a generally poor predictor of gastric disease severity (Strauss et al., 1990 ).
An ancillary aim of this study was to test the hypothesis that dams infected with H. hepaticus during specific gestational stages would produce pups vulnerable to exacerbated liver disease, especially if offspring were inoculated with high doses of bacteria postnatally. This hypothesis was disproven. There were no significant differences between groups exposed to H. hepaticus at or before 3 weeks of age, regardless of intragestational maternal infection protocol. In contrast, a significant resistance to disease was exhibited by mice first inoculated at 12 weeks of age. Thus, H. hepaticus exposure early in life is essential for disease. The finding of putative preneoplastic lesions but not carcinoma at 12 months concurs with other studies of natural and experimental H. hepaticus infection, wherein documentation of tumors prior to 15 months of age is exceedingly rare (Ward et al., 1994a (Ward et al., , 1994b Fox et al., 1996a; Hailey et al., 1998; Avenaud et al., 2003) .
Premalignant liver lesions were restricted to male mice with lobular necrogranulomatous hepatitis, and included poorly circumscribed zones of hepatocellular dysplasia, foci of cellular alteration, and dysplastic nodules. Altered hepatocytes were of the clear cell, eosinophilic, or basophilictigroid variety. We have observed hepatocellular carcinomas containing cells of each of these phenotypes in mice infected with H. hepaticus for 18 months ((Fox et al., 1996a) and unpublished observations). Tigroid hepatocytes, characterized ultrastructurally by orderly stacks of dilated endoplasmic reticulum cisternae richly decorated with ribosomes, were first described in rats used in chemical carcinogenicity studies (Bannasch et al., 1985) . Their physiometabolic origin is uncertain, but they belong to the lineage of basophilic hepatocytes that in rats represent a high risk for malignant transformation (Bannasch and Schroeder, 2002) . To our knowledge, this is the first published report of tigroid hepatocytes in mice. Morphologic consistency with rat tigroid cells was independently verified (P. Bannasch, personal communication) . It is possible that small numbers of tigroid cells may have been overlooked in other mouse studies. Alternatively, the combination of bacterial strain, inoculation protocol, and environment may have uniquely predisposed to tigroid cell formation in our setting. Further investigation will be required to determine whether tigroid cells in mice behave similar to those in rats.
In humans and rodents, hepatocellular carcinoma is more prevalent in males than in females (Kew, 2002) . In the case of hepatitis-associated tumorigenesis, influence of androgens on immune function may be operative. Androgens dampen certain T-cell functions, with the overall effect of reducing Type I and enhancing Type II cytokine responses (Kelley and Duggan, 2003; NIH, 2003) . In addition to effects on the immune system, androgens may act directly as tumor promoters in the liver. Men have higher rates of HCC than women even in the absence of underlying hepatitis. Likewise, malepredominant HCC is described in noninflammatory rodent transgenic viral (Lerat et al., 2002; Okuda et al., 2002) , constitutive proto-oncogene (Santoni-Rugiu et al., 1999) , and chemical carcinogenesis models (Takahashi et al., 2002) . We and others are actively investigating mechanisms underlying sexual dimorphism in hepatocellular carcinogenesis.
In summary, we have shown that early exposure to H. hepaticus is required to produce disease in A/JCr mice. Inflammation severity and intrahepatic bacterial load are positively correlated, suggesting that disease is driven by vigorous but ultimately ineffectual immunity. As with human viral hepatitis, extrahepatic surrogate disease markers are poorly predictive of histologic grade in individuals. Males develop more severe disease than females, but, for reasons unexplained, express a bimodal pattern of susceptibility. Failure of sibling status or cage distribution patterns to predict phenotypic outcomes suggests that disease susceptibility is polyfactorial. Advancing knowledge of disease pathogenesis in A/JCr mice infected with Helicobacter hepaticus will help illuminate our basic understanding of infectious liver cancer.
